These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36521927)

  • 1. Epigenetic modulation of neuroblastoma enhances T cell and NK cell immunogenicity by inducing a tumor-cell lineage switch.
    Cornel AM; Dunnebach E; Hofman DA; Das S; Sengupta S; van den Ham F; Wienke J; Strijker JGM; van den Beemt DAMH; Essing AHW; Koopmans B; Engels SAG; Lo Presti V; Szanto CS; George RE; Molenaar JJ; van Heesch S; Dierselhuis MP; Nierkens S
    J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36521927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic therapies for neuroblastoma: immunogenicity awakens.
    Jiménez C; Moreno L; Segura MF
    Mol Oncol; 2023 May; 17(5):718-721. PubMed ID: 36840349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The narrow-spectrum HDAC inhibitor entinostat enhances NKG2D expression without NK cell toxicity, leading to enhanced recognition of cancer cells.
    Zhu S; Denman CJ; Cobanoglu ZS; Kiany S; Lau CC; Gottschalk SM; Hughes DP; Kleinerman ES; Lee DA
    Pharm Res; 2015 Mar; 32(3):779-92. PubMed ID: 24203492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A transplantable TH-MYCN transgenic tumor model in C57Bl/6 mice for preclinical immunological studies in neuroblastoma.
    Kroesen M; Nierkens S; Ansems M; Wassink M; Orentas RJ; Boon L; den Brok MH; Hoogerbrugge PM; Adema GJ
    Int J Cancer; 2014 Mar; 134(6):1335-45. PubMed ID: 24038106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cells facilitate PRAME-specific T-cell reactivity against neuroblastoma.
    Spel L; Boelens JJ; van der Steen DM; Blokland NJ; van Noesel MM; Molenaar JJ; Heemskerk MH; Boes M; Nierkens S
    Oncotarget; 2015 Nov; 6(34):35770-81. PubMed ID: 26452036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TIM-3 blockade enhances ex vivo stimulated allogeneic NK cell therapy for relapsed murine neuroblastoma after hematopoietic cell transplant.
    Quamine A; Mohrdieck NR; King CA; Griggs AA; Kline JM; Cho MM; Rinella SP; Tippins KE; Bates PD; Shi L; Song L; Hess NJ; Kearl TJ; Johnson BD; Capitini CM
    bioRxiv; 2024 Jul; ():. PubMed ID: 39026718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of new HDAC inhibitors for immunotherapy of malignant pleural mesothelioma.
    Bensaid D; Blondy T; Deshayes S; Dehame V; Bertrand P; Grégoire M; Errami M; Blanquart C
    Clin Epigenetics; 2018; 10():79. PubMed ID: 29946373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase inhibition up-regulates MHC class I to facilitate cytotoxic T lymphocyte-mediated tumor cell killing in glioma cells.
    Sun T; Li Y; Yang W; Wu H; Li X; Huang Y; Zhou Y; Du Z
    J Cancer; 2019; 10(23):5638-5645. PubMed ID: 31737100
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of MICA and MICB Shedding Elicits NK-Cell-Mediated Immunity against Tumors Resistant to Cytotoxic T Cells.
    Ferrari de Andrade L; Kumar S; Luoma AM; Ito Y; Alves da Silva PH; Pan D; Pyrdol JW; Yoon CH; Wucherpfennig KW
    Cancer Immunol Res; 2020 Jun; 8(6):769-780. PubMed ID: 32209637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of NKG2D-ligand cell surface expression enhances immune cell therapy of cancer.
    Huang B; Sikorski R; Sampath P; Thorne SH
    J Immunother; 2011 Apr; 34(3):289-96. PubMed ID: 21389869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRAF inhibitor resistance of melanoma cells triggers increased susceptibility to natural killer cell-mediated lysis.
    Frazao A; Rethacker L; Jeudy G; Colombo M; Pasmant E; Avril MF; Toubert A; Moins-Teisserenc H; Roelens M; Dalac S; Maubec E; Caignard A
    J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32912923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of HLA class I molecules and MHC class I chain-related molecules A/B in K562 and K562/AO2 cell lines and their effects on cytotoxicity of NK cells].
    Mei JZ; Niu XQ; Guo KY; Zhou J; Wei HM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):288-91. PubMed ID: 17493333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An epigenetic vaccine model active in the prevention and treatment of melanoma.
    Khan AN; Magner WJ; Tomasi TB
    J Transl Med; 2007 Dec; 5():64. PubMed ID: 18070359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium valproate, a histone deacetylase inhibitor, augments the expression of cell-surface NKG2D ligands, MICA/B, without increasing their soluble forms to enhance susceptibility of human osteosarcoma cells to NK cell-mediated cytotoxicity.
    Yamanegi K; Yamane J; Kobayashi K; Kato-Kogoe N; Ohyama H; Nakasho K; Yamada N; Hata M; Nishioka T; Fukunaga S; Futani H; Okamura H; Terada N
    Oncol Rep; 2010 Dec; 24(6):1621-7. PubMed ID: 21042760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of effective combination radio-immunotherapy against 9464D-GD2, an immunologically cold murine neuroblastoma.
    Aiken TJ; Erbe AK; Zebertavage L; Komjathy D; Feils AS; Rodriguez M; Stuckwisch A; Gillies SD; Morris ZS; Birstler J; Rakhmilevich AL; Sondel PM
    J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35618290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of NTRK1/TrkA affects immunogenicity of neuroblastoma cells.
    Pajtler KW; Rebmann V; Lindemann M; Schulte JH; Schulte S; Stauder M; Leuschner I; Schmid KW; Köhl U; Schramm A; Eggert A
    Int J Cancer; 2013 Aug; 133(4):908-19. PubMed ID: 23400852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone Deacetylase Inhibitors Enhance CD4 T Cell Susceptibility to NK Cell Killing but Reduce NK Cell Function.
    Pace M; Williams J; Kurioka A; Gerry AB; Jakobsen B; Klenerman P; Nwokolo N; Fox J; Fidler S; Frater J;
    PLoS Pathog; 2016 Aug; 12(8):e1005782. PubMed ID: 27529554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of photodynamic therapy on tumor cell expression of major histocompatibility complex (MHC) class I and MHC class I-related molecules.
    Belicha-Villanueva A; Riddell J; Bangia N; Gollnick SO
    Lasers Surg Med; 2012 Jan; 44(1):60-8. PubMed ID: 22246985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the epigenetic drug MS-275 on the release and function of exosome-related immune molecules in hepatocellular carcinoma cells.
    Xiao W; Dong W; Zhang C; Saren G; Geng P; Zhao H; Li Q; Zhu J; Li G; Zhang S; Ye M
    Eur J Med Res; 2013 Dec; 18(1):61. PubMed ID: 24359553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone deacetylase inhibitors enhance CD1d-dependent NKT cell responses to lymphoma.
    Tiper IV; Webb TJ
    Cancer Immunol Immunother; 2016 Nov; 65(11):1411-1421. PubMed ID: 27614429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.